Dr. Junaid Bajwa, Microsoft Research’s Chief Medical Scientist Appointed Non-Executive Director of Medica

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

March 19, 2021

Dr. Junaid Bajwa will join the Board of Medica as a Non-Executive Director and Chair of the Clinical and Risk Committee on April 1, 2021.

Junaid is a highly skilled individual who brings a wealth of experience with him in his new role at Medica. Junaid is a practicing physician in the NHS and currently occupies the roles of Chief Medical Scientist at Microsoft Research, and as a Non-Executive Director at University College London Hospitals NHS Foundation Trust. He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme (Merck & Co), where he helped shape their global digital strategy. Junaid also has experience in the academic world where he is a Clinical Associate Professor at University College London (UCL), and a Visiting Scientist at the Harvard School of Public Health.

Over the past 15 years, Junaid has worked across primary care, secondary care, and public health settings in addition to acting as a payer, and policymaker within the UK, where he specialized in informatics, digital transformation, and leadership. He has also acted as a consultant for health care systems across the US, Australia, New Zealand, Singapore, the Middle East, and Europe. No further details are required to be disclosed under LR 9.6.13.

Roy Davis, Chairman of Medica, said: “We are delighted to have someone of Junaid’s experience join the Board. His clinical expertise coupled with his digital healthcare and commercial experience will be of enormous benefit to Medica as we continue to expand our technological and telemedicine service offerings internationally. I very much look forward to working with him.”

Commenting on his appointment, Dr. Junaid Bajwa added: “I am very pleased to be joining the board of an exciting and rapidly-growing company. Medica has a compelling strategy in place which speaks directly to my clinical and digital healthcare skill set. I am looking forward to engaging with the Board and the management team and using my expertise to help implement this strategy.”

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.